Yahoo
NYSE - Delayed Quote USD

Albemarle Corporation (ALB)

91.00 -2.27 (-2.43%)
At close: October 30 at 4:00:03 PM EDT
91.00 0.00 (0.00%)
After hours: October 30 at 7:15:19 PM EDT
Trade ALB on Coinbase
Chart Range Bar
Loading chart for ALB

What's happening with ALB?

34m ago
Powered by Yahoo Scout

Albemarle approaches its November 4 earnings report with sharply higher expected earnings and revenue, but falling estimates create uncertainty. Investors will focus on lithium pricing, energy-storage demand, cost savings, and cash generation.

Powered by Yahoo Scout
  • Previous Close 93.27
  • Open 91.42
  • Bid 90.88 x 30000
  • Ask 90.19 x 30000
  • Day's Range 89.77 - 92.19
  • 52 Week Range 88.01 - 221.00
  • Volume 3,609,960
  • Avg. Volume 2,405,218
  • Market Cap (intraday) 10.738B
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) 337.04
  • EPS (TTM) 0.27
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 1.64 (1.80%)
  • 1y Target Est 154.68
  • Morningstar Rating Rating available with Stock Picks access

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

www.albemarle.com

7,800

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALB
35.12%
S&P 500 (^GSPC)
10.73%

1-Year Return

ALB
5.97%
S&P 500 (^GSPC)
11.11%

3-Year Return

ALB
25.13%
S&P 500 (^GSPC)
81.91%

5-Year Return

ALB
61.38%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.74B
Earnings 438.27M
Profit Margin 25.14%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
2B
-20.0%
0.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

83.28
154.68 Average
91.00 Current
211.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/22/2026
Analyst Citigroup
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 175 -> 125

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.80%

  • Return on Assets (ttm)

    3.16%

  • Return on Equity (ttm)

    2.65%

  • Revenue (ttm)

    5.91B

  • Net Income Avi to Common (ttm)

    57.43M

  • Diluted EPS (ttm)

    0.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.63B

  • Total Debt/Equity (mrq)

    18.98%

  • Levered Free Cash Flow (ttm)

    1.33B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: